• Mashup Score: 3

    In this paper we compare two methods for estimating the size of personal networks using a nationally representative sample of the United States. Both methods rely on the ability of respondents to estimate the number of people they know in specific subpopulations of the U.S. (e.g., diabetics, Native Americans) and people in particular relation categories (e.g., immediate family, coworkers). The results demonstrate a remarkable similarity between the average network size generated by both methods (approximately 291). Similar results were obtained with a separate national sample. An attempt to corroborate our estimates by replication among a population we suspect has large networks (clergy), yielded a larger average network size. Extensive investigation into the existence of response effects showed some preference for using certain numbers when making estimates, but nothing that would significantly affect the estimate of network size beyond about 6 percent. We conclude that both methods f

    Tweet Tweets with this article
    • Now, we need a denominator. There is a fairly extensive literature on the mean size of social networks of 'meaningful contacts'. There is no absolute consensus, but most estimates are around ~300. I'll use 291 as estimated in the classical paper below. 8/ https://t.co/Cmjkce5TFy

  • Mashup Score: 1

    AbstractBackground. Postoperative respiratory failure is a major complication that affects up to 10% of patients who undergo cardiac surgery and has a high in-hospital mortality rate. Few studies have investigated whether patients who require tracheostomy for postoperative respiratory failure after continuous-flow left ventricular assist device (CF-LVAD) implantation have worse survival outcomes than patients who do not.Objective. To identify risk factors for respiratory failure necessitating tracheostomy in CF-LVAD recipients and to compare survival outcomes between those who did and did not require tracheostomy.Methods. Consecutive patients who underwent primary CF-LVAD placement at a single institution between August 1, 2002, and December 31, 2019, were retrospectively reviewed. Propensity score matching accounted for baseline differences between the tracheostomy and nontracheostomy groups. Multivariate logistic regression was used to identify tracheostomy risk factors and 90-day su

    Tweet Tweets with this article
    • RT @SXC71: Preop optimization key when looking at Outcomes After LVAD Implantation and Tracheostomy https://t.co/t0Nm49a52P @BCM_Surgery @…

  • Mashup Score: 2

    Mitral and tricuspid valvular disease have been managed surgically; however, multiple transcatheter technologies have diversified the therapeutic arsenal and expanded the number of patients eligible for treatment. These new technologies and active trials currently being performed at The Texas Heart Institute will be highlighted.Transcatheter edge-to-edge repair (TEER) with MitraClip (Abbott Structural Heart) plays an important role in the management of degenerative and functional mitral regurgitation (MR). Despite its success, the limitations of MitraClip include challenging anatomy that may not be amenable to TEER, the common need for multiple devices, risk of device-related mitral stenosis, and a not-trivial rate of residual MR.1 Delivered via a 22F sheath, the PASCAL device (Edwards Lifesciences) offers several improvements.2 Its 3-catheter system (including a guide, steerable, and implantation catheter) offers easy maneuverability in 3 independent planes. It has a spacer that fills

    Tweet Tweets with this article
    • Cutting-edge trials in structural heart disease at The Texas Heart Institute | #THIPubs #GVSilva | @Texas_Heart #THIJournal https://t.co/EHxB1llQzQ

  • Mashup Score: 0
    Taking Back Sunday - 9 month(s) ago

    1 Department of Medicine, Intermountain Medical Center, Intermountain Health, Murray, UT, USA This content is only available as a PDF. Source of Support: None. Conflict of Interest: None. Lewis MA. Taking back Sunday. This work is published under a CC-BY-NC-ND 4.0 International License. This site uses cookies. By continuing to use our website, you are agreeing to our privacy

    Tweet Tweets with this article
    • Taking Back Sunday https://t.co/uf6Wxff3Xk @OncoAlert @OncLive @JIPOEditors @JQSHEditors #burnout